Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability

dc.contributor.authorKrasnopolsky, Yu. M.en
dc.contributor.authorDudnichenko, А. S.en
dc.date.accessioned2022-11-11T13:31:38Z
dc.date.available2022-11-11T13:31:38Z
dc.date.issued2017
dc.description.abstractThe article presents the results of developing the composition and technology of obtaining the liposomal form of docetaxel. The effect of the phospholipid composition of the membrane, ionic strength, pH, temperature, cryoprotectant type, and other factors on the stability of liposomes and the docetaxel incorporation has been considered. Results: Reduction of toxicity of the liposomal form of docetaxel (LD50 – 137 ± 7.7 mg/kg) was found in comparison with its free form (LD50 – 101 ± 6.3 mg/kg). Preservation of nanosize particle after lyophilization has been shown. Conclusions: As a result of the studies, the optimal composition and technological scheme for obtaining liposomes containing docetaxel have been developed allowing large-scale production of docetaxel in liposomal form.en
dc.identifier.citationKrasnopolsky Y. M. Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability / Y. M. Krasnopolsky, А. S. Dudnichenko // Experimental Oncology. – 2017. – Vol. 39, № 2. – P. 121-123.en
dc.identifier.urihttps://repository.kpi.kharkov.ua/handle/KhPI-Press/59158
dc.language.isoen
dc.publisherMorion LLCen
dc.subjectliposomesen
dc.subjectdocetaxelen
dc.subjectliposomal drugsen
dc.subjecttoxicityen
dc.titleExperimental study of liposomal docetaxel analysis of docetaxel incorporation and stabilityen
dc.typeArticleen

Файли

Контейнер файлів

Зараз показуємо 1 - 1 з 1
Ескіз
Назва:
Exp_Oncol_2017_39_2_Krasnopolsky_Experimental_study.pdf
Розмір:
183.06 KB
Формат:
Adobe Portable Document Format
Опис:

Ліцензійна угода

Зараз показуємо 1 - 1 з 1
Ескіз недоступний
Назва:
license.txt
Розмір:
11.25 KB
Формат:
Item-specific license agreed upon to submission
Опис: